To determine whether PRDX2 impacts the Akt/mTOR signaling pathway in NSCLC cells, we examined the expression of important components of this signaling pathway in the siRNA-PRDX2 transfected cells. This evidence concerns the gene PRDX2 and non-small cell lung carcinoma.